Given that inflammation is a significant risk factor for atherosclerosis and the associated macrovascular and microvascular complications, we hypothesized that the mRNA expression of IL-18 and IL-18-BP, along with rs187238 SNP, may have a significant role in CAS development. The gene discussed is IL18; the disease is atherosclerosis.